SCHEMBL12419567

SCHEMBL12419567

OB(O)c1ccc(-c2nnc(-c3cccc4c3OCC4)o2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.37
▸ GSK3B P49841 4/20 0.36
▸ NPC1 O15118 8/20 0.36
▸ RAB9A P51151 8/20 0.36
▸ ALDH1A1 P00352 5/20 0.36
▸ TSHR P16473 5/20 0.36
▸ HPGD P15428 4/20 0.36
▸ SMN1; SMN2 Q16637 4/20 0.36
▸ KDM4E B2RXH2 3/20 0.36
▸ HSD17B10 Q99714 3/20 0.36
▸ TP53 P04637 2/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ CASP3 P42574 1/20 0.36
▸ NFKB2 Q00653 1/20 0.36
▸ RELA Q04206 1/20 0.36
▸ SENP8 Q96LD8 1/20 0.36
▸ SENP7 Q9BQF6 1/20 0.36
▸ SENP6 Q9GZR1 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12419558 0.84 STIM1 (0.39) NPC1RAB9AALDH1A1TSHRHPGD
SCHEMBL12419575 0.79 ALDH1A1 (0.44) NPC1RAB9AALDH1A1TSHRHPGD
SCHEMBL12420282 0.75 RAB9A (0.36) NPC1RAB9AALDH1A1TSHRHPGD
SCHEMBL12419559 0.72 RAB9A (0.53) NPC1RAB9AALDH1A1TSHRHPGD
SCHEMBL12419740 0.72 ALDH1A1 (0.37) NPC1RAB9AALDH1A1TSHRHPGD
SCHEMBL2816834 0.71 NPC1 (0.65) NPC1RAB9AALDH1A1TSHRHPGD
SCHEMBL12419574 0.70 NPC1 (0.52) NPC1RAB9AALDH1A1TSHRHPGD
SCHEMBL16488121 0.68 ATR (0.48) NPC1RAB9AALDH1A1TSHRHPGD
SCHEMBL12508694 0.68 SMN1; SMN2 (0.66) NPC1RAB9AALDH1A1HPGDSMN1; SMN2
SCHEMBL20836119 0.68 PARP1 (0.45) PARP1GSK3BNPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2015-12-24 — — US disclosed
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. (US) 2015-12-24 — — US disclosed
US-8957049-B2 Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS, INC. (US) 2015-02-17 — — US disclosed
US-8957049-B2 Inhibitors of fatty acid amide hydrolase INFINITY PHARMACEUTICALS, INC. (US) 2015-02-17 — — US disclosed
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. 2011-07-14 — — US disclosed
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC. 2011-07-14 — — US disclosed
WO-2009126691-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE INFINITY PHARMACEUTICALS, INC (US) 2009-10-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172186-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 PARP1 2540/4885GSK3B 2045/4885NPC1 472/4885
US-20150368278-A1 INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, ASAH1 PARP1 2540/4885GSK3B 2045/4885NPC1 472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback